Cannabis DePIN & Development Hub

16.0 Cannabis DePIN & Development Hub

PRODUCT DEVELOPMENT & MANUFACTURING (MEDICINAL)

• R&D Centre for medical, and pharmaceutical and nutraceutical development;

• Low-cost environment for conducting controlled trials and studies;

• Streamlined product development in an environment with high-potential interfacing of other natural medicines and compounds;

• Developing an EU-GMP licensed manufacturing facility for New Leaf and White-labeled product;

• International distribution to high-margin markets including Australia and Germany.

Colombia provides the ideal low cost/high quality production center for a bespoke New Leaf Cannabis ‘remedy’ development house.

Our GMP certified raw material and manufacturing facilities will offer a unique foundation for international distribution of affordable quality product lines.

INTERNATIONAL DEPIN PRODUCTION FACILITY (RECREATIONAL)

• New Leaf controls a unique pre-roll production line technology;

• We propose a novel licensing, leasing and royalty arrangement to licensees;

• Licensees selected against a strategic market blueprint, developed by the Investment Committee;

• Major existing Producers with a strategic market position;

• Production lines funded and owned by the New Leaf Fund, in return for ongoing royalty payments;

New Leaf’s ambition is to establish the dominant DePIN pre-roll production ‘House’ of the international recreational markets, delegated to, and operated by, qualified existing Producers. This goal will also delegate product diversity to Licensee’s and individual market demand.